Celesta Ribas Ferreira
Optometrist · Cypress, TXNPI 1518407535
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 94.1% of the total across 65 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. Lumenis BE Inc accounts for 91.5% of it on its own, with 14 other manufacturers making up the rest. 2025 is the largest year on record at $123,864, more than ten times the $17 reported in 2020. Among optometrist clinicians in TX with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 65 payments — averaging $2203.95 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Lumenis BE Inc$131K
- Topcon Healthcare, Inc.$6K
- Alcon$2K
- Biotissue Holdings Inc.$1K
- Sight Sciences, Inc.$600
- Coopervision Inc.$584
- plus $1K from 9 others
What the payments were for
- Consulting fees$6,2754%
- Travel & lodging$2,1141%
- Food & beverage$134,85194%
- Gifts$170%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Lumenis BE Inc | 3 | $131,018 |
| Topcon Healthcare, Inc. | 2 | $6,481 |
| Alcon | 13 | $1,951 |
| Biotissue Holdings Inc. | 9 | $1,166 |
| Sight Sciences, Inc. | 11 | $600 |
| Coopervision Inc. | 6 | $584 |
| Tarsus Pharmaceuticals, Inc. | 4 | $317 |
| Sun Pharmaceutical Industries Inc. | 5 | $313 |
| Carl Zeiss Meditec, Inc. | 2 | $218 |
| Dompe US, Inc. | 2 | $150 |
| Astellas Pharma US Inc | 1 | $122 |
| Bausch & Lomb Americas Inc. | 1 | $121 |
| Carl Zeiss Meditec USA, Inc. | 2 | $113 |
| Oyster Point Pharma, Inc. | 3 | $85 |
| Carl Zeiss Meditec AG | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- M22$127,918
- optilight$3,100
- Clariti Contact Lens$363
- Precision 1$336
- TEARCARE SYSTEM$272
- XDEMVY$263
- MyDay Contact Lens$235
- VisuMax$150
- TearCare SmartLid$145
- TEARCARE(TM) (2.2) SYSTEM KIT$145
- TOTAL30$139
- Precision7$126
- Izervay$122
- INFUSE$121
- CEQUA$118
- Oxervate$117
How this compares
$143,257 in reported general payments places this provider in the 95th percentile of 4,315 optometrist providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Doxycycline Hyclate | 12 | $190 |
Paid to pharmacies, not to this prescriber.
Other optometrist in Cypress
- Derek CunninghamAustin$940K
- Claudio LagunasHouston$644K
- Ashley Wallace-TuckerHouston$547K
- Luis RojasMcKinney$309K
- Emile FadelAustin$225K
- Bridgitte LeeHouston$222K
- Phillip BrunsonHouston$214K
- Jill AutryBellaire$171K
- Stacie VirdenWaco$164K
- Richard PotvinBurleson$153K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.